PMI CEO to Discuss Smoke-Free Transition at Barclays Conference
Event summary
- PMI CEO Jacek Olczak to participate in a fireside chat at the 2026 Barclays Global Consumer Conference on September 8, 2026.
- Smoke-free products accounted for 42% of PMI’s Q2 2026 net revenues.
- PMI has invested over $16 billion since 2008 in developing smoke-free products.
- FDA has authorized marketing of IQOS devices, General snus, and ZYN nicotine pouches.
The big picture
PMI’s focus on smoke-free products reflects a broader industry shift toward harm reduction. The company’s significant R&D investment and FDA approvals position it as a leader in the transition from traditional tobacco. The strategic pivot is critical as global regulations tighten on combustible cigarettes.
What we're watching
- Regulatory Tailwinds
- How FDA approvals will accelerate PMI’s smoke-free product adoption.
- Revenue Shift
- Whether PMI can sustain 42%+ smoke-free revenue contribution.
- Portfolio Expansion
- The pace at which PMI diversifies into wellness areas.